Least likely to cause cardiac failure:
? propranolol (Inderal) ? pindolol (Visken) ? metoprolol (Lopressor)
Major adverse effects of verapamil (Isoptin, Calan) or diltiazem (Cardiazem) IV administration:
? diarrhea ? hypotension ? positive inotropism ? stroke
Same antiarrhythmic classification: disopyramide (Norpace) and
? propranolol (Inderal) ? triamterene (Dyrenium) ? procainamide (Procan SR, Pronestyl-SR) ? bretylium (Bretylol) ? diltiazem (Cardiazem)
Most likely effective in treating supraventricular tachyarrhythmias:
? flecainide (Tambocor) ? esmolol (Brevibloc) ? lidocaine (Xylocaine) ? hydroxyzine (Atarax,Vistaril) ? atropine
A reversible lupus erythematous-like syndrome is most likely associated with this antiarrhythmic drug.
? quinidine gluconate (Quinaglute, Quinalan) ? adenosine (Adenocard) ? carbamazepine (Tegretol) ? procainamide (Procan SR, Pronestyl-SR) ? lidocaine (Xylocaine)
Antiarrhythmic drug most likely to cause seizures (at high concentrations) by direct CNS actions:
? quinidine gluconate (Quinaglute, Quinalan) ? amiodarone (Cordarone) ? lidocaine (Xylocaine) ? phenytoin (Dilantin) ? propranolol (Inderal)
Antiarrhythmic drug, acting at potassium channels:
? adenosine (Adenocard) ? sotalol (Betapace) ? diltiazem (Cardiazem) ? esmolol (Brevibloc) ? quinidine gluconate (Quinaglute, Quinalan)
Cinchonism: adverse effect associated with this antiarrhythmic drug.
? procainamide (Procan SR, Pronestyl-SR) ? verapamil (Isoptin, Calan) ? quinidine gluconate (Quinaglute, Quinalan) ? flecainide (Tambocor) ? adenosine (Adenocard)
Antiarrhythmic drug, administered IV, typically used to suppress ventricular arrhythmias associated with acute myocardial infarction:
? amiodarone (Cordarone) ? metoprolol (Lopressor) ? lidocaine (Xylocaine) ? phenytoin (Dilantin) ? esmolol (Brevibloc)
Despite being a myocardial depressant, this antiarrhythmic drug's anticholinergic properties facilitate AV nodal transmission:
? phenytoin (Dilantin) ? amiodarone (Cordarone) ? adenosine (Adenocard) ? quinidine gluconate (Quinaglute, Quinalan) ? diltiazem (Cardiazem)
Changes in cardiac automaticity is most directly associated with changes in which slope of the myocardial action potential?
? phase 0 ? phase 1 ? phase 2 ? phase 3 ? phase 4
Contraindicated in asthmatic patients, this antiarrhythmic drug blocks beta-1 receptors.
? adenosine (Adenocard) ? lidocaine (Xylocaine) ? procainamide (Procan SR, Pronestyl-SR) ? propranolol (Inderal) ? none of the above
Class II antiarrhythmic drug
? adenosine (Adenocard) ? atropine ? esmolol (Brevibloc) ? lidocaine (Xylocaine) ? mexiletine (Mexitil)
Muscarinic receptor antagonist, this antiarrhythmic drug may be effective in managing bradycardia.
? esmolol (Brevibloc) ? adenosine (Adenocard) ? lidocaine (Xylocaine) ? atropine ? mexiletine (Mexitil)
Calcium channel blocker -- effective in treating supraventricular arrhythmias:
? tocainide (Tonocard) ? verapamil (Isoptin, Calan) ? quinidine gluconate (Quinaglute, Quinalan) ? procainamide (Procan SR, Pronestyl-SR) ? heparin
Class III antiarrhythmic drug may be effective in treating ventricular arrhythmias; prolongs phase 3 (repolarization); potassium channel blocker
? esmolol (Brevibloc) ? amiodarone (Cordarone) ? lidocaine (Xylocaine) ? propafenone (Rythmol) ? moricizine (Ethmozine)
Naturally occurring metabolites, given by IV administration, this antiarrhythmic agent slows conduction through the AV node
? esmolol (Brevibloc) ? adenosine (Adenocard) ? lidocaine (Xylocaine) ? procainamide (Procan SR, Pronestyl-SR) ? bretylium (Bretylol)
Digoxin (Lanoxin, Lanoxicaps) is useful in treating high ventricular rates in patients with atrial fibrillation because:
? digoxin (Lanoxin, Lanoxicaps) is a good drug for stopping atrial fibrillation ? digoxin (Lanoxin, Lanoxicaps) increases cardiac contractility ? digoxin (Lanoxin, Lanoxicaps) slows conduction through the AV node; therefore it reduces heart rate ? digoxin (Lanoxin, Lanoxicaps) is metabolized in the liver ? digoxin (Lanoxin, Lanoxicaps) is inexpensive
Antiarrhythmic drug likely to increase heart rate:
? tocainide (Tonocard) ? verapamil (Isoptin, Calan) ? quinidine gluconate (Quinaglute, Quinalan) ? propranolol (Inderal) ? esmolol (Brevibloc)
Always administered by IV because of significant first-pass effect, this anti-rhythmic drug suppresses ventricular arrhythmias associated with acute myocardial infarction; CNS side effects are prominent in overdosage.
? verapamil (Isoptin, Calan) ? propranolol (Inderal) ? lidocaine (Xylocaine) ? amiodarone (Cordarone) ? quinidine gluconate (Quinaglute, Quinalan)